Flora Growth Corp. (FLGC)
USD 0.46
(0.65%)
USD 0.46
(0.65%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 17.73 Million USD | -86.57% |
| 2022 | 14.41 Million USD | 494.39% |
| 2021 | 2.42 Million USD | 3315.49% |
| 2020 | 71 Thousand USD | 374.5% |
| 2019 | -25.86 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 549 Thousand USD | 115.74% |
| 2024 Q1 | 1.46 Million USD | 261.58% |
| 2023 Q1 | 5.47 Million USD | 89.06% |
| 2023 FY | 1.93 Million USD | -86.57% |
| 2023 Q4 | 406 Thousand USD | -91.78% |
| 2023 Q3 | 4.94 Million USD | 24.8% |
| 2023 Q2 | 3.96 Million USD | -27.7% |
| 2022 Q2 | 3.87 Million USD | 45.17% |
| 2022 FY | 14.41 Million USD | 494.39% |
| 2022 Q1 | 2.67 Million USD | 236.27% |
| 2022 Q4 | 2.89 Million USD | -41.72% |
| 2022 Q3 | 4.97 Million USD | 28.25% |
| 2021 FY | 2.42 Million USD | 3315.49% |
| 2021 Q1 | 506 Thousand USD | 1325.35% |
| 2021 Q4 | 794 Thousand USD | 28.27% |
| 2021 Q3 | 619 Thousand USD | 39.1% |
| 2021 Q2 | 445 Thousand USD | -12.06% |
| 2020 Q3 | 35.5 Thousand USD | 229.48% |
| 2020 Q2 | -27.41 Thousand USD | 6.1% |
| 2020 FY | 71 Thousand USD | 374.5% |
| 2020 Q1 | -29.19 Thousand USD | 0.0% |
| 2020 Q4 | 35.5 Thousand USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 FY | -25.86 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 326.16 Million USD | 94.562% |
| Embecta Corp. | 749.9 Million USD | 97.635% |
| ANI Pharmaceuticals, Inc. | 305.3 Million USD | 94.19% |
| Dynavax Technologies Corporation | 182.11 Million USD | 90.26% |
| Esperion Therapeutics, Inc. | 73.06 Million USD | 75.724% |
| Pacira BioSciences, Inc. | 490.3 Million USD | 96.382% |
| PainReform Ltd. | -15 Thousand USD | 118353.333% |
| Aquestive Therapeutics, Inc. | 29.75 Million USD | 40.38% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | -112.707% |
| SCYNEXIS, Inc. | 124.51 Million USD | 85.755% |
| China SXT Pharmaceuticals, Inc. | 553.97 Thousand USD | -3101.973% |
| Cosmos Health Inc. | 4.34 Million USD | -307.811% |
| Journey Medical Corporation | 52.52 Million USD | 66.227% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | -112.707% |
| Safety Shot Inc | -74.45 Thousand USD | 23923.146% |
| Alpha Teknova, Inc. | 10.29 Million USD | -72.28% |
| Intra-Cellular Therapies, Inc. | 430.62 Million USD | 95.881% |
| Bright Green Corporation | -237.01 Thousand USD | 7583.883% |
| Procaps Group, S.A. | 239.56 Million USD | 92.596% |
| Theratechnologies Inc. | 62.12 Million USD | 71.45% |
| Harrow Health, Inc. | 90.55 Million USD | 80.411% |
| Sonoma Pharmaceuticals, Inc. | 4.74 Million USD | -273.825% |
| Biofrontera Inc. | 16.62 Million USD | -6.682% |
| DURECT Corporation | 6.83 Million USD | -159.669% |
| Supernus Pharmaceuticals, Inc. | 523.74 Million USD | 96.613% |
| Cronos Group Inc. | 6.99 Million USD | -153.73% |
| OptiNose, Inc. | 62.35 Million USD | 71.553% |
| Ironwood Pharmaceuticals, Inc. | 441.16 Million USD | 95.979% |
| Kala Pharmaceuticals, Inc. | -303 Thousand USD | 5954.125% |
| RedHill Biopharma Ltd. | 3.05 Million USD | -480.779% |
| Organogenesis Holdings Inc. | 309.79 Million USD | 94.274% |
| Guardion Health Sciences, Inc. | 5.39 Million USD | -228.815% |
| Cumberland Pharmaceuticals Inc. | 33.48 Million USD | 47.028% |
| Radius Health, Inc. | 307.71 Million USD | 94.236% |
| Universe Pharmaceuticals INC | 10.07 Million USD | -76.009% |
| ProPhase Labs, Inc. | 16.23 Million USD | -9.231% |
| Phibro Animal Health Corporation | 312.48 Million USD | 94.324% |
| Procaps Group S.A. | 239.56 Million USD | 92.596% |
| Alvotech | -69.42 Million USD | 125.551% |
| TherapeuticsMD, Inc. | 1.3 Million USD | -1262.366% |
| Viatris Inc. | 6.43 Billion USD | 99.725% |
| Rockwell Medical, Inc. | 8.7 Million USD | -103.791% |
| Aytu BioPharma, Inc. | 54.58 Million USD | 67.504% |
| SIGA Technologies, Inc. | 122.09 Million USD | 85.472% |
| Tilray Brands, Inc. | 223.35 Million USD | 92.058% |
| Lifecore Biomedical, Inc. | 41.85 Million USD | 57.615% |
| Shineco, Inc. | 882.16 Thousand USD | -1910.728% |
| PetIQ, Inc. | 252.74 Million USD | 92.982% |
| Regencell Bioscience Holdings Limited | -745.58 Thousand USD | 2479.062% |
| Incannex Healthcare Limited | 12 Thousand USD | -147716.667% |
| Neurocrine Biosciences, Inc. | 1.84 Billion USD | 99.04% |
| Alimera Sciences, Inc. | 61.17 Million USD | 71.002% |
| Silver Spike Investment Corp. | 8.1 Million USD | -118.917% |
| Assertio Holdings, Inc. | 125.04 Million USD | 85.815% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6811.00 USD | 260531.655% |
| Petros Pharmaceuticals, Inc. | 4.19 Million USD | -323.223% |
| Clever Leaves Holdings Inc. | 6.55 Million USD | -170.561% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 835.963% |
| Avadel Pharmaceuticals plc | 27.11 Million USD | 34.587% |
| Hempacco Co., Inc. | -1.21 Million USD | 1558.917% |
| Talphera, Inc. | -4.89 Million USD | 462.37% |
| Alvotech | -69.42 Million USD | 125.551% |
| Eagle Pharmaceuticals, Inc. | 221.67 Million USD | 91.998% |
| Lantheus Holdings, Inc. | 709.54 Million USD | 97.5% |
| Currenc Group, Inc. | 17.35 Million USD | -2.199% |
| Kamada Ltd. | 52.59 Million USD | 66.273% |
| Indivior PLC | 907 Million USD | 98.044% |
| Evoke Pharma, Inc. | 4.97 Million USD | -256.274% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 835.963% |
| Evolus, Inc. | 140.52 Million USD | 87.377% |
| HUTCHMED (China) Limited | 453.55 Million USD | 96.089% |
| Amphastar Pharmaceuticals, Inc. | 343.96 Million USD | 94.843% |
| Akanda Corp. | 111.44 Thousand USD | -15815.8% |